Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 412


Capsule biopsy of acellular dermal matrix (ADM) to predict future capsular contracture in two-stage prosthetic breast reconstruction.

Kim A, Jung JH, Choi YL, Pyon JK.

J Plast Reconstr Aesthet Surg. 2019 May 22. pii: S1748-6815(19)30222-0. doi: 10.1016/j.bjps.2019.05.021. [Epub ahead of print] No abstract available.


Co-expression of MDM2 and CDK4 in transformed human mesenchymal stem cells causes high-grade sarcoma with a dedifferentiated liposarcoma-like morphology.

Kim YJ, Kim M, Park HK, Yu DB, Jung K, Song K, Choi YL.

Lab Invest. 2019 Jun 3. doi: 10.1038/s41374-019-0263-4. [Epub ahead of print]


Removal of U(VI) by sugar-based magnetic pseudo-graphene oxide and its application to authentic groundwater using electromagnetic system.

Choi YL, Choi JS, Lingamdinne LP, Chang YY, Koduru JR, Ha JH, Yang JK.

Environ Sci Pollut Res Int. 2019 Jun 1. doi: 10.1007/s11356-019-05260-5. [Epub ahead of print]


Combination therapy with c-met inhibitor and TRAIL enhances apoptosis in dedifferentiated liposarcoma patient-derived cells.

Jo EB, Lee YS, Lee H, Park JB, Park H, Choi YL, Hong D, Kim SJ.

BMC Cancer. 2019 May 24;19(1):496. doi: 10.1186/s12885-019-5713-2.


Histopathologic characteristics of advanced-stage ROS1-rearranged non-small cell lung cancers.

Park E, Choi YL, Ahn MJ, Han J.

Pathol Res Pract. 2019 Jul;215(7):152441. doi: 10.1016/j.prp.2019.152441. Epub 2019 May 6.


Adipogenesis induces growth inhibition of dedifferentiated liposarcoma.

Kim YJ, Yu DB, Kim M, Choi YL.

Cancer Sci. 2019 May 8. doi: 10.1111/cas.14036. [Epub ahead of print]


Identification of tumor suppressor miRNAs by integrative miRNA and mRNA sequencing of matched tumor-normal samples in lung adenocarcinoma.

Yu N, Yong S, Kim HK, Choi YL, Jung Y, Kim D, Seo J, Lee YE, Baek D, Lee J, Lee S, Lee JE, Kim J, Kim J, Lee S.

Mol Oncol. 2019 Jun;13(6):1356-1368. doi: 10.1002/1878-0261.12478. Epub 2019 Apr 18.


Repeat biopsy procedures and T790M rates after afatinib, gefitinib, or erlotinib therapy in patients with lung cancer.

Lee K, Kim Y, Jung HA, Lee SH, Ahn JS, Ahn MJ, Park K, Choi YL, Sun JM.

Lung Cancer. 2019 Apr;130:87-92. doi: 10.1016/j.lungcan.2019.01.012. Epub 2019 Jan 28.


Transthoracic Rebiopsy for Mutation Analysis in Lung Adenocarcinoma: Outcomes and Risk Factors for the Acquisition of Nondiagnostic Specimens in 199 Patients.

Nam BD, Kim TJ, Park K, Ahn MJ, Choi YL, Chung MJ, Kim TS, Lee KS.

Clin Lung Cancer. 2019 May;20(3):e309-e316. doi: 10.1016/j.cllc.2018.12.021. Epub 2018 Dec 31.


Cloning, purification, and characterization of an organic solvent-tolerant chitinase, MtCh509, from Microbulbifer thermotolerans DAU221.

Lee HJ, Lee YS, Choi YL.

Biotechnol Biofuels. 2018 Nov 8;11:303. doi: 10.1186/s13068-018-1299-1. eCollection 2018.


Comparing CMR Mapping Methods and Myocardial Patterns Toward Heart Failure Outcomes in Nonischemic Dilated Cardiomyopathy.

Vita T, Gräni C, Abbasi SA, Neilan TG, Rowin E, Kaneko K, Coelho-Filho O, Watanabe E, Mongeon FP, Farhad H, Rassi CH, Choi YL, Cheng K, Givertz MM, Blankstein R, Steigner M, Aghayev A, Jerosch-Herold M, Kwong RY.

JACC Cardiovasc Imaging. 2018 Nov 8. pii: S1936-878X(18)30749-6. doi: 10.1016/j.jcmg.2018.08.021. [Epub ahead of print]


Status of programmed death-ligand 1 expression in sarcomas.

Park HK, Kim M, Sung M, Lee SE, Kim YJ, Choi YL.

J Transl Med. 2018 Nov 6;16(1):303. doi: 10.1186/s12967-018-1658-5.


Concurrent Genetic Alterations Predict the Progression to Target Therapy in EGFR-Mutated Advanced NSCLC.

Kim Y, Lee B, Shim JH, Lee SH, Park WY, Choi YL, Sun JM, Ahn JS, Ahn MJ, Park K.

J Thorac Oncol. 2019 Feb;14(2):193-202. doi: 10.1016/j.jtho.2018.10.150. Epub 2018 Nov 1.


Abrupt Dyskeratotic and Squamoid Cells in Poorly Differentiated Carcinoma: Case Study of Two Thoracic NUT Midline Carcinomas with Cytohistologic Correlation.

Lee T, Choi S, Han J, Choi YL, Lee K.

J Pathol Transl Med. 2018 Sep;52(5):349-353. doi: 10.4132/jptm.2018.07.16. Epub 2018 Jul 27.


Clinical Outcomes of EGFR Exon 20 Insertion Mutations in Advanced Non-small Cell Lung Cancer in Korea.

Byeon S, Kim Y, Lim SW, Cho JH, Park S, Lee J, Sun JM, Choi YL, Lee SH, Ahn JS, Park K, Ahn MJ.

Cancer Res Treat. 2019 Apr;51(2):623-631. doi: 10.4143/crt.2018.151. Epub 2018 Jul 23.


Efficacy of mesna, doxorubicin, ifosfamide, and dacarbazine (MAID) in patients with advanced pulmonary pleomorphic carcinoma.

Lee J, Jung HA, Kim Y, Choi S, Han J, Choi YL, Lee SH, Ahn JS, Park K, Sun JM.

Lung Cancer. 2018 Aug;122:160-164. doi: 10.1016/j.lungcan.2018.06.009. Epub 2018 Jun 9.


EGFR Mutation Is Associated with Short Progression-Free Survival in Patients with Stage III Non-squamous Cell Lung Cancer Treated with Concurrent Chemoradiotherapy.

Park SE, Noh JM, Kim YJ, Lee HS, Cho JH, Lim SW, Ahn YC, Pyo H, Choi YL, Han J, Sun JM, Lee SH, Ahn JS, Park K, Ahn MJ.

Cancer Res Treat. 2019 Apr;51(2):493-501. doi: 10.4143/crt.2018.125. Epub 2018 Jun 18.


Pembrolizumab for Patients With Refractory or Relapsed Thymic Epithelial Tumor: An Open-Label Phase II Trial.

Cho J, Kim HS, Ku BM, Choi YL, Cristescu R, Han J, Sun JM, Lee SH, Ahn JS, Park K, Ahn MJ.

J Clin Oncol. 2018 Jun 15:JCO2017773184. doi: 10.1200/JCO.2017.77.3184. [Epub ahead of print]


Integrin β3 Inhibition Enhances the Antitumor Activity of ALK Inhibitor in ALK-Rearranged NSCLC.

Noh KW, Sohn I, Song JY, Shin HT, Kim YJ, Jung K, Sung M, Kim M, An S, Han J, Lee SH, Lee MS, Choi YL.

Clin Cancer Res. 2018 Sep 1;24(17):4162-4174. doi: 10.1158/1078-0432.CCR-17-3492. Epub 2018 May 18.


Genomic alterations of ground-glass nodular lung adenocarcinoma.

Lee H, Joung JG, Shin HT, Kim DH, Kim Y, Kim H, Kwon OJ, Shim YM, Lee HY, Lee KS, Choi YL, Park WY, Hayes DN, Um SW.

Sci Rep. 2018 May 16;8(1):7691. doi: 10.1038/s41598-018-25800-2.


Multi-omics profiling of younger Asian breast cancers reveals distinctive molecular signatures.

Kan Z, Ding Y, Kim J, Jung HH, Chung W, Lal S, Cho S, Fernandez-Banet J, Lee SK, Kim SW, Lee JE, Choi YL, Deng S, Kim JY, Ahn JS, Sha Y, Mu XJ, Nam JY, Im YH, Lee S, Park WY, Nam SJ, Park YH.

Nat Commun. 2018 Apr 30;9(1):1725. doi: 10.1038/s41467-018-04129-4.


Engrailed 1 overexpression as a potential prognostic marker in quintuple-negative breast cancer.

Kim YJ, Sung M, Oh E, Vrancken MV, Song JY, Jung K, Choi YL.

Cancer Biol Ther. 2018 Apr 3;19(4):335-345. doi: 10.1080/15384047.2018.1423913. Epub 2018 Feb 13.


Droplet digital PCR-based EGFR mutation detection with an internal quality control index to determine the quality of DNA.

Kim SS, Choi HJ, Kim JJ, Kim MS, Lee IS, Byun B, Jia L, Oh MR, Moon Y, Park S, Choi JS, Chae SW, Nam BH, Kim JS, Kim J, Min BS, Lee JS, Won JK, Cho SY, Choi YL, Shin YK.

Sci Rep. 2018 Jan 11;8(1):543. doi: 10.1038/s41598-017-18642-x.


Genes co-amplified with ERBB2 or MET as novel potential cancer-promoting genes in gastric cancer.

Kwon MJ, Kim RN, Song K, Jeon S, Jeong HM, Kim JS, Han J, Hong S, Oh E, Choi JS, An J, Pollack JR, Choi YL, Park CK, Shin YK.

Oncotarget. 2017 Sep 21;8(54):92209-92226. doi: 10.18632/oncotarget.21150. eCollection 2017 Nov 3.


ESRP1 is overexpressed in ovarian cancer and promotes switching from mesenchymal to epithelial phenotype in ovarian cancer cells.

Jeong HM, Han J, Lee SH, Park HJ, Lee HJ, Choi JS, Lee YM, Choi YL, Shin YK, Kwon MJ.

Oncogenesis. 2017 Nov 20;6(11):e391. doi: 10.1038/oncsis.2017.89.


Prevalence and detection of low-allele-fraction variants in clinical cancer samples.

Shin HT, Choi YL, Yun JW, Kim NKD, Kim SY, Jeon HJ, Nam JY, Lee C, Ryu D, Kim SC, Park K, Lee E, Bae JS, Son DS, Joung JG, Lee J, Kim ST, Ahn MJ, Lee SH, Ahn JS, Lee WY, Oh BY, Park YH, Lee JE, Lee KH, Kim HC, Kim KM, Im YH, Park K, Park PJ, Park WY.

Nat Commun. 2017 Nov 9;8(1):1377. doi: 10.1038/s41467-017-01470-y.


Clinical benefit and residual kidney function of en bloc nephrectomy for perirenal retroperitoneal sarcoma.

Cho CW, Lee KW, Park H, Kim HJ, Park JB, Choi YL, Yu JI, Lee SJ, Choi DI, Kim SJ.

Asia Pac J Clin Oncol. 2018 Oct;14(5):e465-e471. doi: 10.1111/ajco.12769. Epub 2017 Oct 18.


ESRP1 is overexpressed in ovarian cancer and promotes switching from mesenchymal to epithelial phenotype in ovarian cancer cells.

Jeong HM, Han J, Lee SH, Park HJ, Lee HJ, Choi JS, Lee YM, Choi YL, Shin YK, Kwon MJ.

Oncogenesis. 2017 Oct 9;6(10):e389. doi: 10.1038/oncsis.2017.87. Erratum in: Oncogenesis. 2017 Nov 20;6(11):e391.


Targeted exome sequencing of Korean triple-negative breast cancer reveals homozygous deletions associated with poor prognosis of adjuvant chemotherapy-treated patients.

Jeong HM, Kim RN, Kwon MJ, Oh E, Han J, Lee SK, Choi JS, Park S, Nam SJ, Gong GY, Nam JW, Choi DH, Lee H, Nam BH, Choi YL, Shin YK.

Oncotarget. 2017 Jun 27;8(37):61538-61550. doi: 10.18632/oncotarget.18618. eCollection 2017 Sep 22.


Unforeseen clonal evolution of tumor cell population in recurrent and metastatic dermatofibrosarcoma protuberans.

Oh E, Jeong HM, Kwon MJ, Ha SY, Park HK, Song JY, Kim YJ, Choi JS, Lee EH, Lee J, Choi YL, Shin YK.

PLoS One. 2017 Oct 4;12(10):e0185826. doi: 10.1371/journal.pone.0185826. eCollection 2017.


Comparison of retroperitoneal liposarcoma extending into the inguinal canal and inguinoscrotal liposarcoma.

Rhu J, Cho CW, Lee KW, Park H, Park JB, Choi YL, Kim SJ.

Can J Surg. 2017 Dec;60(6):399-407.


Effect of HPV E6/E7 siRNA with Chemotherapeutic Agents on the Regulation of TP53/E2F Dynamic Behavior for Cell Fate Decisions.

Rajasekaran N, Jung HS, Bae SH, Chelakkot C, Hong S, Choi JS, Yim DS, Oh YK, Choi YL, Shin YK.

Neoplasia. 2017 Oct;19(10):735-749. doi: 10.1016/j.neo.2017.07.005. Epub 2017 Aug 24.


Girdin protein expression is associated with poor prognosis in patients with invasive breast cancer.

Choi JS, Kim KH, Oh E, Shin YK, Seo J, Kim SH, Park S, Choi YL.

Pathology. 2017 Oct;49(6):618-626. doi: 10.1016/j.pathol.2017.05.010. Epub 2017 Aug 14.


Single-center experience with intra-abdominal liposarcoma: Optimal minimum duration for postoperative remnant tumor screening.

Rhu J, Cho CW, Lee KW, Park H, Park JB, Choi YL, Kim SJ.

Medicine (Baltimore). 2017 Aug;96(33):e7537. doi: 10.1097/MD.0000000000007537.


Radical Nephrectomy for Primary Retroperitoneal Liposarcoma Near the Kidney has a Beneficial Effect on Disease-Free Survival.

Rhu J, Cho CW, Lee KW, Park H, Park JB, Choi YL, Kim SJ.

World J Surg. 2018 Jan;42(1):254-262. doi: 10.1007/s00268-017-4157-6.


Precision medicine approaches to lung adenocarcinoma with concomitant MET and HER2 amplification.

Oh DY, Jung K, Song JY, Kim S, Shin S, Kwon YJ, Oh E, Park WY, Song SY, Choi YL.

BMC Cancer. 2017 Aug 10;17(1):535. doi: 10.1186/s12885-017-3525-9.


Therapeutic strategies for locally recurrent and metastatic de-differentiated liposarcoma with herpes simplex virus-thymidine kinase-expressing mesenchymal stromal cells.

Lee H, Jo EB, Kim SJ, Yang HM, Kim YM, Sung YC, Park JB, Hong D, Park H, Choi YL, Kim SJ.

Cytotherapy. 2017 Sep;19(9):1035-1047. doi: 10.1016/j.jcyt.2017.05.008. Epub 2017 Jul 29.


Molecular breakdown: a comprehensive view of anaplastic lymphoma kinase (ALK)-rearranged non-small cell lung cancer.

Noh KW, Lee MS, Lee SE, Song JY, Shin HT, Kim YJ, Oh DY, Jung K, Sung M, Kim M, An S, Han J, Shim YM, Zo JI, Kim J, Park WY, Lee SH, Choi YL.

J Pathol. 2017 Nov;243(3):307-319. doi: 10.1002/path.4950. Epub 2017 Sep 28.


Programmed Death Ligand 1 Expression in Paired Non-Small Cell Lung Cancer Tumor Samples.

Cho JH, Sorensen SF, Choi YL, Feng Y, Kim TE, Choi H, Georgsen JB, Dolled-Filhart M, Emancipator K, Meldgaard P, Sun JM, Kim HK, Choi YS, Shim YM, Zhou W, Hager H, Kim J.

Clin Lung Cancer. 2017 Nov;18(6):e473-e479. doi: 10.1016/j.cllc.2017.04.008. Epub 2017 Apr 24.


Systematic identification of cancer-related long noncoding RNAs and aberrant alternative splicing of quintuple-negative lung adenocarcinoma through RNA-Seq.

Zhang L, Li S, Choi YL, Lee J, Gong Z, Liu X, Pei Y, Jiang A, Ye M, Mao M, Zhang X, Kim J, Chen R.

Lung Cancer. 2017 Jul;109:21-27. doi: 10.1016/j.lungcan.2017.04.009. Epub 2017 Apr 21.


Genomic profiling of esophageal squamous cell carcinoma (ESCC)-Basis for precision medicine.

Yang JW, Choi YL.

Pathol Res Pract. 2017 Jul;213(7):836-841. doi: 10.1016/j.prp.2017.02.021. Epub 2017 Feb 28.


Good Laboratory Standards for Clinical Next-Generation Sequencing Cancer Panel Tests.

Kim J, Park WY, Kim NKD, Jang SJ, Chun SM, Sung CO, Choi J, Ko YH, Choi YL, Shim HS, Won JK; Molecular Pathology Study Group of Korean Society of Pathologists.

J Pathol Transl Med. 2017 May;51(3):191-204. doi: 10.4132/jptm.2017.03.14. Epub 2017 May 10. Review.


Complete genome sequence and analysis of three kinds of β-agarase of Cellulophaga lytica DAU203 isolated from marine sediment.

Lee YS, Choi YL.

Mar Genomics. 2017 Oct;35:43-46. doi: 10.1016/j.margen.2017.05.005. Epub 2017 May 18.


MET Exon 14 Skipping Mutations in Lung Adenocarcinoma: Clinicopathologic Implications and Prognostic Values.

Lee GD, Lee SE, Oh DY, Yu DB, Jeong HM, Kim J, Hong S, Jung HS, Oh E, Song JY, Lee MS, Kim M, Jung K, Kim J, Shin YK, Choi YL, Kim HR.

J Thorac Oncol. 2017 Aug;12(8):1233-1246. doi: 10.1016/j.jtho.2017.04.031. Epub 2017 May 10.


Molecular Testing of Lung Cancers.

Shim HS, Choi YL, Kim L, Chang S, Kim WS, Roh MS, Kim TJ, Ha SY, Chung JH, Jang SJ, Lee GK; Korean Cardiopulmonary Pathology Study Group; Korean Molecular Pathology Study Group.

J Pathol Transl Med. 2017 May;51(3):242-254. doi: 10.4132/jptm.2017.04.10. Epub 2017 Apr 21. Review.


MMP11 and CD2 as novel prognostic factors in hormone receptor-negative, HER2-positive breast cancer.

Han J, Choi YL, Kim H, Choi JY, Lee SK, Lee JE, Choi JS, Park S, Choi JS, Kim YD, Nam SJ, Nam BH, Kwon MJ, Shin YK.

Breast Cancer Res Treat. 2017 Jul;164(1):41-56. doi: 10.1007/s10549-017-4234-4. Epub 2017 Apr 13.


The effects of different hinge positions on posterior tibial slope in medial open-wedge high tibial osteotomy.

Jo HS, Park JS, Byun JH, Lee YB, Choi YL, Cho SH, Moon DK, Lee SH, Hwang SC.

Knee Surg Sports Traumatol Arthrosc. 2018 Jun;26(6):1851-1858. doi: 10.1007/s00167-017-4526-6. Epub 2017 Apr 7.


Supplemental Content

Support Center